Axa
IMGN

Axa’s Immunogen Inc IMGN Stock Holding History

Axa’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-44,800
Closed -$845K – 1177
2023
Q2 		$845K Buy
44,800
+11,900
+36% +$141K ﹤0.01% 864
2023
Q1 		$126K Buy
+32,900
New +$140K ﹤0.01% 1080
2021
Q4 		– Sell
-268,500
Closed -$1.52M – 1303
2021
Q3 		$1.52M Buy
+268,500
New +$1.55M ﹤0.01% 910
2021
Q2 		– Sell
-56,400
Closed -$457K – 1318
2021
Q1 		$457K Hold
56,400
– – ﹤0.01% 1087
2020
Q4 		$364K Hold
56,400
– – ﹤0.01% 1111
2020
Q3 		$203K Sell
56,400
-102,300
-64% -$413K ﹤0.01% 1155
2020
Q2 		$730K Hold
158,700
– – ﹤0.01% 1003
2020
Q1 		$541K Buy
158,700
+87,100
+122% +$381K ﹤0.01% 955
2019
Q4 		$366K Buy
+71,600
New +$243K ﹤0.01% 1044
2019
Q2 		– Sell
-30,744
Closed -$83K – 1379
2019
Q1 		$83K Sell
30,744
-25,100
-45% -$109K ﹤0.01% 1299
2018
Q4 		$268K Buy
+55,844
New +$339K ﹤0.01% 1191
2018
Q3 		– Sell
-20,007
Closed -$195K – 1405
2018
Q2 		$195K Buy
20,007
+1,463
+8% +$15.4K ﹤0.01% 1304
2018
Q1 		$195K Sell
18,544
-162,856
-90% -$1.61M ﹤0.01% 1326
2017
Q4 		$1.16M Buy
181,400
+100,200
+123% +$618K ﹤0.01% 969
2017
Q3 		$621K Sell
81,200
-226,600
-74% -$1.51M ﹤0.01% 1068
2017
Q2 		$2.19M Buy
307,800
+256,900
+505% +$1.18M 0.01% 767
2017
Q1 		$197K Buy
+50,900
New +$149K ﹤0.01% 1225

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Axa's IMGN Position: Q3 2023 in Review

Axa sold out of Immunogen Inc (IMGN) in Q3 2023, closing a stake of 44,800 shares — an estimated $845K sold.

Axa first reported a position in IMGN in Q1 2017 and held it in 17 quarters. The position peaked at $2.19M in Q2 2017. 275 funds tracked by Wall St. Rank hold IMGN as of Q3 2023.

  • Axa reported no remaining Immunogen Inc position as of Q3 2023 after selling out during the quarter.
  • Axa sold 44,800 Immunogen Inc shares in Q3 2023, an estimated $845K.
  • Axa first reported a position in Immunogen Inc in Q1 2017 and held it in 17 quarters.
  • Axa's Immunogen Inc position peaked at $2.19M in Q2 2017.
  • 275 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2023.

Based on Axa's 13F filing for Q3 2023, filed 14 Nov 2023.